The RASSF1A gene is frequently inactivated by aberrant promoter hypermethylation in the majority of human malignancies, including breast, lung, gastrointestinal, bladder, head and neck cancer and gynecological cancers, endometrial and cervical cancer [23]. The gene discussed is RASSF1; the disease is cervical carcinoma.